Uncategorized

Autism awareness really is growing, but harmful misconceptions still remain

By editor
May 15, 2023

Los Angeles Times By Laura Newberry April 18, 2023 (Patrick Hruby / Los Angeles Times) Instagram and TikTok have been flooded with content made for and by neurodivergent people in recent years. In turn, many people have come across these videos and had life-changing realizations that they might be autistic or have attention-deficit hyperactivity disorder...   read more


Abortion pill fight may have broader implications for FDA drug approval

By editor
May 15, 2023

The Washington Post By Rachel Roubein, Laurie McGinley and David Ovalle March 15, 2023 Legal experts say a Texas judge’s ruling on mifepristone may sow chaos in how the agency regulates medicines The legal battle over an abortion pill threatens to upend the Food and Drug Administration’s drug-approval process, a system viewed as the global gold standard...   read more


4 ways to break the cycle of intergenerational trauma

By editor
March 24, 2023

The Washington Post By Jason Wu March 23, 2023 A parent’s unresolved trauma can affect a child’s well-being. By cultivating a healthy relationship with anger, making space for all feelings, knowing that true love comes with understanding and by meeting your child’s need, you can break the cycle. Unresolved trauma from one generation affects the...   read more


Most trans adults say transitioning made them more satisfied with their lives

By editor
March 24, 2023

The Washington Post By Casey Parks, Emily Guskin and Scott Clement March 23, 2023 The Washington Post and KFF surveyed one of the largest randomized samples of U.S. transgender adults to date about their childhoods, feelings and lives Transgender Americans experience stigma and systemic inequality in many aspects of their lives, including education, work and...   read more


Opioid Settlement Hinders Patients’ Access to a Wide Array of Drugs

By editor
March 24, 2023

The New York Times By Christina Jewett and Ellen Gabler March 13, 2023 An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain. Nearly a year after a sweeping opioid settlement imposed new requirements on the companies that provide medications to pharmacies, patients across the United...   read more


A Fraught New Frontier in Telehealth: Ketamine

By editor
March 24, 2023

The New York Times By Chris Hamby Feb. 20, 2023 Ketamine can be mind-altering, and getting it has become much easier. Many mental health patients call the drug lifesaving. But some complain of bladder ailments, inadequate oversight and addiction. Is this good medicine, or telehealth run amok? With loosened rules around remote prescriptions, a psychedelic-like...   read more


Bosses say they care about mental health — can workers trust them?

By editor
March 24, 2023

Los Angeles Times By Denise Guerra, Samantha Masunaga Feb. 23, 2023 (Hanna Barczyk / For The Times) Faced with high levels of worker stress, anxiety and burnout as a result of the COVID-19 pandemic, many companies pledged that employee mental health would become a top priority. Firms promised manager training to ensure bosses were more...   read more


A.D.H.D. Can Strain Relationships. Here’s How Couples Cope.

By editor
March 24, 2023

The New York Times By Christina Caron Feb. 18, 2022 The symptoms of attention deficit hyperactivity disorder can push couples to their breaking point, but there is hope for those willing to seek help. When Chris Lawson began dating Alexandra Salamis, the woman who would eventually become his partner, he was “Mr. Super Attentive Dude,”...   read more


Psilocybin as mental health therapy? Here’s what I found.

By editor
March 24, 2023

The Washington Post By Steven Petrow September 5, 2022 Interest in and use of the drug is growing, but much is unknown A few weeks ago, I mentioned to a friend that I was interested in learning more about psychedelics, especially how they might help me with depression and anxiety. That’s a broad category of...   read more


Psychedelics are a Promising Therapy, but They Can Be Dangerous for Some

By editor
March 24, 2023

The New York Times By Dana G. Smith Feb. 10, 2023 While drugs like ketamine and psilocybin are largely considered safe, here’s what to know about who should be cautious. When Dr. Charles Nemeroff first met his patient, the 32-year-old woman had already been to see several psychiatrists. Initially, the woman, whose identity has been...   read more